A future for hyperthermia in cancer treatment?
- 1 September 2001
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (13) , 1587-1589
- https://doi.org/10.1016/s0959-8049(01)00193-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II studyEuropean Journal Of Cancer, 2001
- Improving Local Tumor Control by Combining Vascular Targeting Drugs, Mild Hyperthermia and RadiationActa Oncologica, 2001
- Hyperthermic radiosensitization: mode of action and clinical relevanceInternational Journal of Radiation Biology, 2001
- A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinomaInternational Journal of Hyperthermia, 2001
- Hyperthermia in oncologyInternational Journal of Hyperthermia, 2001
- Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trialThe Lancet, 2000
- Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitorInternational Journal of Hyperthermia, 1999
- Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.Journal of Clinical Oncology, 1998
- Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanomaThe Lancet, 1995
- The current and potential role of hyperthermia in radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1989